Boston Scientific Corp. will add a "single-shot" radiofrequency (RF) pulmonary vein isolation balloon catheter for treating atrial fibrillation (AF) to its portfolio by acquiring Apama Medical Inc. for a total of $300m.
Boston Scientific announced Oct. 2 that it has agreed to pay $175m in cash up-front, plus up to of $125m in contingent payments through 2020, for the Campbell, California-based privately...